Eugia Drug Patent Portfolio
Eugia owns 1 orange book drug protected by 1 US patent Given below is the list of Eugia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9662342 | Formulations of cyclophosphamide liquid concentrate | 26 Jun, 2035 | Active |
Latest Legal Activities on Eugia's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eugia.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed | 02 Mar, 2026 | US11382923 |
| Recordation of Patent Grant Mailed | 24 Jun, 2025 | US12329767 |
| Recordation of Patent eGrant | 17 Jun, 2025 | US12329767 |
| Patent eGrant Notification | 17 Jun, 2025 | US12329767 |
| Patent Issue Date Used in PTA Calculation | 17 Jun, 2025 | US12329767 |
| Email Notification | 17 Jun, 2025 | US12329767 |
| Mail Patent eGrant Notification | 17 Jun, 2025 | US12329767 |
| Email Notification | 05 Jun, 2025 | US12329767 |
| Issue Notification Mailed | 04 Jun, 2025 | US12329767 |
| Application Is Considered Ready for Issue | 16 May, 2025 | US12329767 |
| Dispatch to FDC | 16 May, 2025 | US12329767 |
| Issue Fee Payment Received | 15 May, 2025 | US12329767 |
| Issue Fee Payment Verified | 15 May, 2025 | US12329767 |
| Mail Notice of Allowance | 03 Apr, 2025 | US12329767 |
| Email Notification | 03 Apr, 2025 | US12329767 |
Eugia's Family Patents
Recent FDA approvals and tentative approvals for Eugia
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Nintedanib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 04 Feb, 2026 |
| Carfilzomib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 25 Nov, 2022 |
| Palbociclib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 07 Jul, 2022 |
Eugia Drug List
Given below is the complete list of Eugia's drugs and the patents protecting them.
1. Cyclophosphamide
Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9662342 | Formulations of cyclophosphamide liquid concentrate |
26 Jun, 2035
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page